By: Björn

New PAASP publication: ‘The reproducibility crisis in preclinical research – lessons to learn from clinical research’
January 23, 2018

In this article, Laia Pedro-Roig and Christoph Emmerich discuss ways and measures how preclinical research and development (especially in its confirmatory…

Read More
Newsletter January 2018
January 23, 2018

PAASP News: – PAASP is part of the BMBF-funded GOT-IT Project – Read more – New PAASP publication (‘The reproducibility crisis…

Read More
PAASP is part of the BMBF-funded GOT-IT (‘Guidelines On Target Validation for Innovative Therapeutics’) Project
January 23, 2018

Medical progress and continued supply of innovative medicines can only be guaranteed by continuous research and development of new active drugs…

Read More
Meetings in 2017
December 30, 2017

June 28, 2017 – Webinar (11 AM – 12 PM EST ) Seminar by Carlijn Hooijmans presenting the Grading of Recommendations…

Read More
IMI Call9: PAASP is part of the EQIPD consortium and co-leads the work package responsible for developing a new quality management system to improve preclinical data robustness
December 19, 2017

A consortium of pharma companies, SMEs and academic researchers launched an ambitious project to address research quality as one of the…

Read More
The link between Portfolio Evolution and the Robustness of early phase drug discovery data
December 19, 2017

The reproducibility discussion involves everyone who funds, authorizes, supervises, plans, conducts and publishes research. This recent LifeSciVC post showed that lacking research rigor…

Read More
Asking a question makes writing abstracts easy
December 19, 2017

Writing papers that have titles posed as questions isn’t very common, but perhaps it should be. It makes wiritng the abstract…

Read More
After the Nature checklists – what’s next?
December 19, 2017

In the November issue of our Newsletter, we have featured a publication by the NPQIP Collaborative Group (LINK) that analyzed the…

Read More
The link between Portfolio Evolution and the Robustness of early phase drug discovery data
December 19, 2017

The reproducibility discussion involves everyone who funds, authorizes, supervises, plans, conducts and publishes research. This recent LifeSciVC post showed that lacking…

Read More
Additional reads in December 2017
December 19, 2017

Further commentaries, articles and blog posts worth reading: Rewarding negative results keeps science on track Research health needs a dedicated group…

Read More